Phase II Dose Titration Study in Patients With Neuropathic Pain

Clinical trial NCT00736151 · COMPLETED

Trial details

NCT number: NCT00736151
Sponsor: Newron Pharmaceuticals SPA
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuropathic Pain

Start date: 2004-05-01
Primary completion: 2007-04-01
Enrollment: 272

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.